We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+40.41%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.93B
AUM Growth
+$710M
Cap. Flow
+$347M
Cap. Flow %
17.99%
Top 10 Hldgs %
33.69%
Holding
94
New
31
Increased
15
Reduced
22
Closed
18

Top Buys

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$61.8M
2
LH icon
Labcorp
LH
+$50M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$48.9M
4
AZN icon
AstraZeneca
AZN
+$32.8M
5
HOLX
Hologic
HOLX
+$30.1M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$38.5M
2
BDX icon
Becton Dickinson
BDX
+$34.7M
3
CI icon
Cigna
CI
+$34.5M
4
ELV icon
Elevance Health
ELV
+$33.1M
5
COR icon
Cencora
COR
+$30M

Sector Composition

Rank Sector Weight
1 Healthcare 66.7%
2 Technology 4.27%
3 Consumer Discretionary 1.32%
4 Industrials 0.62%
5 Financials 0.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPD
26
DELISTED
PPD, Inc. Common Stock
PPD
$28.8M 1.49%
1,073,491
+595,748
+125% +$14.9M
EW icon
27
Edwards Lifesciences
EW
$49.6B
$27.2M 1.41%
393,435
+38,259
+11% +$2.72M
FXI icon
28
PUT
iShares China Large-Cap ETF
FXI
$4.37B
$26.3M 1.37%
+663,200
New +$25.9M
ELV icon
29
Elevance Health
ELV
$81.5B
$26.3M 1.36%
100,000
-123,925
-55% -$33.1M
CAH icon
30
CALL
Cardinal Health
CAH
$53.9B
$26.1M 1.35%
+500,000
New +$25.8M
BAX icon
31
Baxter International
BAX
$13.5B
$25.4M 1.32%
295,222
-14,413
-5% -$1.26M
TEVA icon
32
Teva Pharmaceuticals
TEVA
$40.8B
$25.1M 1.3%
+2,034,296
New +$23M
ZBH icon
33
Zimmer Biomet
ZBH
$18.2B
$21.5M 1.11%
+185,288
New +$21.4M
PEN icon
34
Penumbra
PEN
$12.7B
$19.9M 1.03%
111,302
-6,888
-6% -$1.2M
ICUI icon
35
CALL
ICU Medical
ICUI
$4.21B
$19.8M 1.02%
+107,200
New +$21.3M
MSFT icon
36
Microsoft
MSFT
$3.45T
$19.4M 1%
95,177
– –
MNTA
37
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$19.3M 1%
+579,994
New +$18.5M
XYZ
38
Block Inc
XYZ
$48.4B
$19M 0.99%
+181,509
New +$13.9M
HCA icon
39
CALL
HCA Healthcare
HCA
$87.2B
$17.4M 0.9%
+179,600
New +$18.7M
ICLR icon
40
Icon
ICLR
$12.6B
$17.3M 0.9%
102,966
+10,520
+11% +$1.66M
VRTX icon
41
Vertex Pharmaceuticals
VRTX
$121B
$17.1M 0.89%
59,035
-36,447
-38% -$9.88M
MOH icon
42
Molina Healthcare
MOH
$10.2B
$16.6M 0.86%
93,168
-31,276
-25% -$5.33M
UNH icon
43
UnitedHealth
UNH
$376B
$16.5M 0.86%
55,910
-48,812
-47% -$14M
ARNA
44
DELISTED
Arena Pharmaceuticals Inc
ARNA
$16.5M 0.85%
261,808
-487,409
-65% -$26.8M
HALO icon
45
Halozyme
HALO
$9.79B
$16M 0.83%
597,545
-21,181
-3% -$478K
DCPH
46
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$14.9M 0.77%
250,133
+43,797
+21% +$2.34M
AMZN icon
47
Amazon
AMZN
$2.92T
$14.7M 0.76%
106,840
– –
NXPI icon
48
NXP Semiconductors
NXPI
$57.8B
$14.6M 0.76%
+127,871
New +$12.8M
NVDA icon
49
NVIDIA
NVDA
$4.86T
$14.5M 0.75%
1,524,520
-949,160
-38% -$7.68M
EXAS
50
DELISTED
Exact Sciences
EXAS
$14.1M 0.73%
+161,679
New +$12.9M
1
2
3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q2 2020 Portfolio in Review

As of Q2 2020, PFM Health Sciences held 94 positions worth $1.93B, up 58% from $1.22B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

PFM Health Sciences deployed $347M of net new capital in Q2 2020, opening 31 new positions and adding to 15 existing holdings. Its largest new stake was Labcorp: 361,224 shares worth $51.5M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, down from 84% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Elevance Health, an estimated $33.1M trimmed.

  • PFM Health Sciences's largest Q2 2020 buy was Labcorp: 361,224 shares worth $51.5M.
  • PFM Health Sciences added most to Immunomedics Inc in Q2 2020, an estimated $61.8M increase.
  • PFM Health Sciences's biggest Q2 2020 reduction was Elevance Health, cutting an estimated $33.1M.
  • PFM Health Sciences fully exited Pfizer in Q2 2020, selling an estimated $38.5M.
  • PFM Health Sciences's ten largest holdings make up 34% of its $1.93B portfolio in Q2 2020.
  • PFM Health Sciences opened 31 new positions and closed 18 in Q2 2020.
  • PFM Health Sciences's portfolio value rose 58% quarter-over-quarter to $1.93B.

Based on PFM Health Sciences's 13F filing for Q2 2020, filed 14 Aug 2020.